Showing results (2021-2030 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|February 12, 2004
Psychometric Validation of the National Eye Institute Visual Function Questionnaire - 25 (NEI VFQ-25) French version: in a population of patients treated for ocular hypertension and glaucomaJean-Phillipe Nordmann, Muriel Viala, Kate Sullivan, et al.Pharmacoeconomics|January 21, 2004
The generation gap: differences between children and adults pertinent to economic evaluations of health interventionsRon Keren, Susmita Pati, Chris FeudtnerPharmacoeconomics|January 21, 2004
Cost of stress urinary incontinence: a claims data analysisHoward G Birnbaum, Stephanie A Leong, Emily F Oster, et al.Pharmacoeconomics|April 8, 2003
Health-related quality of life and regulatory issues in the US and CanadaJudith GlenniePharmacoeconomics|April 8, 2003
A pharmacy-based health promotion programme in hypertension: cost-benefit analysisIsabelle Côté, Jean-Pierre Grégoire, Jocelyne Moisan, et al.Pharmacoeconomics|April 6, 2004
Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databasesL Clark Paramore, Vincent Ciuryla, Gabrielle Ciesla, et al.Pharmacoeconomics|April 6, 2004
Cost effectiveness of representatives of three classes of antidepressants used in major depression in the UKAlan Lenox-Smith, Pete Conway, Chris KnightPharmacoeconomics|August 6, 2004
Incorporation of statistical uncertainty in health economic modelling studies using second-order Monte Carlo simulationsMark J C NuijtenPharmacoeconomics|August 6, 2004
Assessing the use of retrospective databases in conducting economic evaluations of drugs: the case of asthmaFredrik BerggrenPharmacoeconomics|May 26, 2004
Drugs that block tumour necrosis factor: experience in patients with rheumatoid arthritisLarry W MorelandPageof 336